
Share on:
Joint replacement is the largest segment in orthopedics, accounting for $19 billion in revenue or 35% of the global market. Its size combined with its adoption of enabling and digital technologies makes joint replacement an attractive space for portfolio expansions, partnerships and acquisitions. Our latest market dive highlights the current and projected size of the segment; the top 10 companies in knee, hip and extremities by revenue; and key trends and executive insights.
RELATED ARTICLES
AVNA Names Chip Harvill as Senior Business Development Executive
May 05 2025 , Julie A. Vetalice
Lincotek and Promimic Enter Strategic License Agreement
Apr 23 2025 , Julie A. Vetalice
Trump’s Tariffs Offer Opportunity for Supply Chain Improvement
Apr 23 2025 , BONEZONE Editors